Navigation Links
Subsidiary in Medical Technology

Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials

... leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: ... Informatics Perceptive Informatics, a subsidiary of PAREXEL, is the industry's leading eClinical ... reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology ...

Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers

... Cardium Therapeutics (NYSE Amex: CXM ) and its subsidiary Tissue Repair Company (TRC) today announced the ... indications. Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company ... For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including ...

Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs

... leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: ... Informatics Perceptive Informatics, a subsidiary of PAREXEL, is the industry's leading eClinical ... reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology ...

Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimer's Treatments

... leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: ... Informatics Perceptive Informatics, a subsidiary of PAREXEL, is the industry's leading eClinical ... reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology ...

Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack

... indications. Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company ... For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including ... development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth ...

Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology

... indications. Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company ... For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including ... development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth ...

Cardium Reports on Second Quarter 2008 Highlights and Financial Results

... in the level of activity on the grant at our subsidiary Tissue Repair Company. Cash and cash equivalents ... . Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company ... . Cardium's Tissue Repair Company subsidiary (TRC) is a San Diego-based biopharmaceutical ...

Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities

... . Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company ... For more information about Cardium's InnerCool subsidiary and patient temperature modulation, ... . Cardium's Tissue Repair Company subsidiary (TRC) is a San Diego-based biopharmaceutical ...

Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack

... About InnerCool InnerCool Therapies, Inc., a subsidiary of Cardium Therapeutics, Inc., is a San ... . Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company ... For more information about Cardium's InnerCool subsidiary and patient temperature modulation, ...

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

... collaboration with Shire Human Genetic Therapies, Inc., a wholly-owned subsidiary of Shire plc, to jointly develop Amicus' three lead pharmacological ... collaboration with Shire Human Genetic Therapies, Inc., a wholly-owned subsidiary of Shire Limited, to develop and commercialize Amicus' three lead ...

Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat

... and PHOENIX, June 2 /PRNewswire/ -- Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW ), and World Wide Wheat (W3) LLC ... growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at ....

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

... completion of the oil palm genome in 2008. ACGT is a wholly owned subsidiary of Asiatic Development Berhad, an oil palm plantation company and a member ... Berhad/ACGT Asiatic Development Berhad ("Asiatic"), a 55%-owned subsidiary of Genting Berhad, commenced its operations in 1980 as the plantation arm ...

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

... Mich., May 19 /PRNewswire-FirstCall/ -- Terumo Heart Inc., a wholly owned subsidiary of Terumo Corporation, today announced reaching a critical milestone in ... About Terumo Heart, Inc. Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in ...

Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients

... was Terumo Heart, Inc., maker of the DuraHeart System and a wholly owned subsidiary of Terumo Corporation. "In a patient population with advanced disease ... About Terumo Heart, Inc. Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in ...

Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient

... by Terumo Heart, Inc., maker of the DuraHeart System and a wholly owned subsidiary of Terumo Corporation. The DuraHeart System is the first third-generation ... About Terumo Heart, Inc. Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in ...

TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee

... In Asia, TissueGene has licensed intellectual property rights to KLS, a subsidiary of Kolon, for the clinical development and commercialization of ... About Kolon Life Science, Inc. Kolon Life Science, Inc. (KLS), a subsidiary company of Kolon, is a leading biochemical company in Korea focused on ...

FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation

... North America Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that ... . About Eisai Inc. Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd. that was established in 1995 and is ranked among the ...

YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia

... products for patients worldwide, today announced that its majority-owned subsidiary CIMYM BioSciences Inc. received a milestone payment from its licensee ... of nimotuzumab in the Philippines and Indonesia. IGK is the biotech subsidiary of P.T Kalbe Farma Tbk (Jakarta, Indonesia), one of the largest ...

Phase III Data Demonstrate Efficacy and Tolerability of Carisbamate as an Adjunctive Therapy for Partial Onset Seizures

... Pharmaceutical Research & Development, L.L.C. (J&JPRD) is a subsidiary of Johnson & Johnson, the world's most broadly-based producer of ... Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, focuses exclusively on providing solutions that ...

Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI

... developed and markets Perforomist(TM) Inhalation Solution. Dey, L.P. is a subsidiary of Mylan Inc. (NYSE: MYL ). About COPD(1) COPD refers to a number of ... and ask for Customer Service. About Dey, L.P. Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

... FINANCIAL TABLES ATTACHED - CURAGEN CORPORATION AND subsidiary CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS ... - (1,853) - (2,991) Gain on sale of subsidiary - 78,352 - 78,352 Income from discontinued ...

Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study

... study treatment (irrespective of whether it was active or placebo). In the subsidiary safety analyses, a total of 158 patients were recorded with a serious ... not support the suggestion of an increase in cancer that was raised by the subsidiary analyses of the relatively small numbers of cancers in the SEAS study. ...

iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix

... virtual colonoscopy CAD product, in partnership with ACR Image Metrix, a subsidiary of the American College of Radiology (ACR). iCAD and ACR Image Metrix, ... to CT Colonography." About ACR Image Metrix ACR Image Metrix is a subsidiary of the American College of Radiology (ACR), the premier professional ...

Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.

... March 5, 2008, Arno, Laurier and Laurier Acquisition, Inc., a wholly-owned subsidiary of Laurier, entered into a merger agreement pursuant to which Laurier Acquisition would merge into Arno, with Arno becoming the wholly-owned subsidiary of Laurier. The merger was completed on June 3, 2008. Immediately ...

Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women

... WellPoint's Health Outcomes Research subsidiary HealthCore Presents Data on Contributing Factors and Steps that Could Be ... work to improve care and outcomes among this population." HealthCore, a subsidiary of WellPoint, is a health outcomes and clinical research organization that ...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

... developed and markets Perforomist(TM) Inhalation Solution. Dey, L.P. is a subsidiary of Mylan Inc. (NYSE: MYL ). About Perforomist(TM) Inhalation Solution ... may be right for them. About Dey, L.P. Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused ...

SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver

... April 9, 2008 /PRNewswire/ -- SpineMark CRO Management, a wholly owned subsidiary of SpineMark Corporation, is collaborating with Los Angeles- and ... About SpineMark CRO Management SpineMark CRO Management, a wholly owned subsidiary of SpineMark Corporation, is transforming the way spine research is ...

Cardium and Tissue Repair Company's Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.

... please visit http://www.cardiumthx.com . Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of ... please visit http://www.innercool.com . Cardium's Tissue Repair Company subsidiary (TRC) is a San Diego-based biopharmaceutical company focused on the ...

Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies

... of development. Microbia Precision Engineering, Inc., a majority-owned subsidiary of Microbia, Inc., is an industrial biotechnology company developing and ... Sankyo, Inc.; and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmstadt, Germany. Except for the historical information ...

FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents

... Feb. 29 /PRNewswire/ -- Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., announced today that the Food and Drug ... of North America Eisai Corporation of North America is a wholly-owned subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company ...

Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity

... and clinical studies and commercialization; (iv) the ability of Nastech, a subsidiary and/or a partner to obtain required governmental approvals; and (v) the ability of Nastech, a subsidiary and/or a partner to develop and commercialize products that can compete ...

Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD

... developed and markets Perforomist(TM) Inhalation Solution. Dey, L.P. is a subsidiary of Mylan Inc. (NYSE: MYL ). About Perforomist(TM) Inhalation Solution ... with short-acting bronchodilators. About Dey, L.P. Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused ...

Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007

... treatment of COPD - NAPA, Calif., Oct. 16 /PRNewswire/ -- Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL ), announces three clinical data presentations ... with short-acting bronchodilators. About Dey, L.P. Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL ), is a specialty pharmaceutical company focused ...

Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)

... Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company ... Inc., and Campral is a registered trademark of Merck Sante s.a.s., subsidiary of Merck KGaA, Darmstadt, Germany. Except for the historical information ...

Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies

... SYSTEM AND IBIS BIOSCIENCES, INC. Ibis Biosciences, Inc., a wholly owned subsidiary of Isis Pharmaceuticals, has developed the Ibis T5000(TM) Biosensor System ... in the future, human infectious disease diagnostics. Bruker Daltonics, a subsidiary of Bruker BioSciences Corporation, is globally responsible for ...

Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP

... Aug. 20 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has ... Inc. (RPI) based in Jacksonville, Florida, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical ...

Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine

... -- Carrington Laboratories, Inc. (Nasdaq: CARN ) today announced its subsidiary DelSite Biotechnologies, Inc. has initiated the animal toxicology studies ... comply with cGMP standards. Carrington's DelSite Biotechnologies subsidiary is developing its proprietary GelSite(R) technology designed to provide ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... Limited and other Elan affiliates. NanoCrystal((R)) Technology is a registered trademark of Elan Pharma International Limited, Ireland, a subsidiary of Elan Corporation plc (NYSE: ELN ). The NanoCrystal((R)) Technology is a proven, robust, drug optimization technology, enabling solubility for ...

Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System

... for the Anaconda(TM) AAA (Abdominal Aortic Aneurysm) Stent Graft System in the U.S. The Anaconda system is manufactured by Scotland-based Terumo subsidiary Vascutek Ltd. The first U.S. implant was performed on June 8th at Arizona Heart Hospital by the principal investigator, Julio Rodriguez-Lopez, M.D. ...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

... field for its development of Campto Injection (Camptosar), the first-line drug for colorectal cancer in the U.S. Yakult U.S.A. Inc., the subsidiary of Yakult Honsha Co., Ltd., is stationed in Torrance, CA. For more information, please visit http://www.yakult.co.jp/english , ...
Other Contents
(Date:9/23/2014)... moving body relies on an orchestrated response of bones, joints, ... literally the geometry of a critical part like ... just a footfall error at the root of one of ... cruciate ligament tear. In fact, size of the femoral ... and volume of the ACL combine to influence the ...
(Date:9/23/2014)... MADISON, Wis. A multidisciplinary team at the University ... creating a faster, more affordable way to screen for ... development. , The National Institutes of Health (NIH) announced ... 11 universities receiving support to continue the promising work ... program. The team will receive approximately $7 million over ...
(Date:9/23/2014)... Health will award funds to support the next phase ... improve ways of predicting drug safety and effectiveness. Researchers ... human tissue chips and combine them into an integrated ... human body. Led by the National Center for Advancing ... at $17 million in 2014 with additional support over ...
Breaking Biology News(10 mins):Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4
(Date:9/23/2014)... analysis of published studies found that FDG-PET technology ... benign disease in regions where infections like histoplasmosis ... lesions suspicious for cancer could lead to unnecessary ... complications and mortality. , Histoplasmosis and other ... often concentrated in bird droppings and are found ...
(Date:9/23/2014)... 2014 World of Home Fitness is ... Most recently, the gym has been raising money to ... Throughout the year, World of Home Fitness has participated ... , Over the summer, World of Home Fitness raised ... Ageless Fitness program, participants helped feed seniors "one rep ...
(Date:9/23/2014)... As a consumer in today’s world, ... It’s difficult to trust testimonials that are supplied by ... manipulate their customers into saying anything. , Consumer advocacy ... to lack in depth coverage on a particular market ... to fix this issue and focus on exposing the ...
(Date:9/23/2014)... HealthDay Reporter TUESDAY, Sept. ... got paid for providing better care, not ... informed health choices. A new report suggests that,s ... report, from the IMS Institute for Healthcare Informatics in Parsippany, ... to alter the delivery of health care and use of ...
(Date:9/23/2014)... Genomic medicine is rapidly developing, bringing with its ... and optimize prevention and treatment interventions. Genetic ... immunodeficiency virus (HIV) and hepatitis c virus (HPC), ... be used to screen for an individual,s susceptibility ... treatments for addiction. , While there appear to ...
Breaking Medicine News(10 mins):Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:World of Home Fitness Supports Meals on Wheels 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2
Other TagsOther Tags